109 related articles for article (PubMed ID: 37548201)
41. Association of Stathmin (Op18) with TNM Staging and Grading of Oral Squamous Cell Carcinoma and Its Role in Tumor Progression.
Vadla P; Deepthi G; Julakanti V; Jahagirdar D; Meruva S; Tantravahi S
J Contemp Dent Pract; 2022 May; 23(5):497-502. PubMed ID: 35986456
[TBL] [Abstract][Full Text] [Related]
42. Clinical value of peripheral blood M2/M1 like monocyte ratio in the diagnosis of breast cancer and the differentiation between benign and malignant breast tumors.
Fadhil M; Abdul-Rasheed O; Al-Naqqash M
Acta Biochim Pol; 2019 Dec; 66(4):437-443. PubMed ID: 31794652
[TBL] [Abstract][Full Text] [Related]
43. SHH Expression Is Significantly Associated With Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma.
Cierpikowski P; Lis-Nawara A; Bar J
Anticancer Res; 2021 Nov; 41(11):5405-5413. PubMed ID: 34732409
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
45. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
46. Laminin γ2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via integrin α3-dependent uptake by lymphatic endothelial cells.
Wang SH; Liou GG; Liu SH; Chang JS; Hsiao JR; Yen YC; Chen YL; Wu WL; Chang JY; Chen YW
Int J Cancer; 2019 Jun; 144(11):2795-2810. PubMed ID: 30485433
[TBL] [Abstract][Full Text] [Related]
47. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
48. Sentinel node-assisted neck dissection in advanced oral squamous cell carcinoma-A new protocol for staging and treatment.
Bark R; Kolev A; Elliot A; Piersiala K; Näsman A; Grybäck P; Georén SK; Wendt M; Cardell LO; Margolin G; Marklund L
Cancer Med; 2023 Jun; 12(11):12524-12534. PubMed ID: 37084007
[TBL] [Abstract][Full Text] [Related]
49. Frequency of circulating CD14
Song Y; Zhou Q; Zhu H; Jing Y; Zhang X; Yang Y; Hu Q; Huang X; Ni Y
J Oral Pathol Med; 2018 Nov; 47(10):923-929. PubMed ID: 29961993
[TBL] [Abstract][Full Text] [Related]
50. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
[TBL] [Abstract][Full Text] [Related]
51. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
52. Tumor microenvironment and Oral Squamous Cell Carcinoma: A crosstalk between the inflammatory state and tumor cell migration.
Alves A; Diel L; Ramos G; Pinto A; Bernardi L; Yates J; Lamers M
Oral Oncol; 2021 Jan; 112():105038. PubMed ID: 33129055
[TBL] [Abstract][Full Text] [Related]
53. Systemic inflammatory response in predicting outcomes of patients undergoing curative resection for oral squamous cell carcinoma.
Zubair F; McMahon J; Kryklyas G; Wicks C
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):589-595. PubMed ID: 35248409
[TBL] [Abstract][Full Text] [Related]
54. Lymphoscintigraphy and radio-guided neck dissection in oral cavity squamous cell carcinoma.
Malagutti N; Panareo S; Ciorba A; Corazzi V; Borin M; Bianchini C; Stomeo F; Bartolomei M; Pelucchi S
J BUON; 2020; 25(3):1587-1593. PubMed ID: 32862608
[TBL] [Abstract][Full Text] [Related]
55. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
[TBL] [Abstract][Full Text] [Related]
56. Corneodesmosin as a potential target of oral squamous cell carcinoma.
Di YB; Bao Y; Guo J; Liu W; Zhang SX; Zhang GH; Li TK
Medicine (Baltimore); 2022 Sep; 101(39):e28397. PubMed ID: 36181011
[TBL] [Abstract][Full Text] [Related]
57. Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma.
Erber R; Spoerl S; Mamilos A; Krupar R; Hartmann A; Ruebner M; Taxis J; Wittenberg M; Reichert TE; Spanier G; Spoerl S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008509
[TBL] [Abstract][Full Text] [Related]
58. Distant metastasis in oral squamous cell carcinoma: Does the neutrophil-to-lymphocyte ratio act as a surrogate of the host immune status?
Zanoni DK; Valero C; McGill MR; Montero PH; Shah JP; Wong RJ; Ganly I; Patel SG
Oral Oncol; 2022 Jan; 124():105641. PubMed ID: 34864297
[TBL] [Abstract][Full Text] [Related]
59. Impact of lymph node ratio on survival and recurrence outcomes in oral squamous cell carcinoma.
Mamic M; Lucijanic M; Lorencin M; Suton P; Luksic I
Int J Oral Maxillofac Surg; 2022 Oct; 51(10):1257-1263. PubMed ID: 35101318
[TBL] [Abstract][Full Text] [Related]
60. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
